JNK and ERK mitogen-activated protein kinases mediate THDA-induced apoptosis in K562 cells

Cell Biology and Toxicology

Volumn 24, Issue 4, 2008, Pages 291-302

  Yang, Sheng Huei ^a   Wu, Zchong Zcho ^a   Chien, Ching Ming ^a   Lo, Yu Hsiang ^a   Wu, Ming Jung ^a   Chang, Long Sen ^b   Lin, Shinne Ren ^a,b  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^b NATIONAL SUN YAT SEN UNIVERSITY   (Taiwan)

Author keywords

Apoptosis; ERK; JNK; K562 cells; THDA

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 [6 (2 THIEANISYL) 3(Z) HEXEN 1, 5 DIYNYL]ANILINE; ANILINE DERIVATIVE; CASPASE 3; CASPASE 9; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN BAX; STRESS ACTIVATED PROTEIN KINASE; X LINKED INHIBITOR OF APOPTOSIS;

APOPTOSIS; ARTICLE; CELL STRAIN K 562; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; UPREGULATION;

ANILINE COMPOUNDS; ANTINEOPLASTIC AGENTS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CASPASE 3; CASPASE 9; ENEDIYNES; ENZYME ACTIVATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; K562 CELLS; LEUKEMIA, ERYTHROBLASTIC, ACUTE; PHOSPHORYLATION; PROTEIN KINASE INHIBITORS; PROTO-ONCOGENE PROTEINS C-JUN; SIGNAL TRANSDUCTION; TIME FACTORS; X-LINKED INHIBITOR OF APOPTOSIS PROTEIN;

EID: 45749098201     PISSN: 07422091     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10565-007-9038-6     Document Type: Article

References (29)

1. Adams JM, Cory S. The Bcl-2 protein family: arbiters of cell survival. Science 1998;281:1322-6.
2. Alabugin IV, Manoharan M, Kovalenko SV. Tuning rate of the bergman cyclization of benzannelated enediynes with ortho substituents. Org Lett 2002;4:1119-22.
3. Antonsson B, Martinou JC. The Bcl-2 protein family. Exp Cell Res 2000;2561:50-7.
4. Bacus SS, Gudkov AV, Lowe M, Lyass L, Yung Y, Komarov AP, et al. Taxol-induced apoptosis depends on MAP kinase pathways (ERK and p38) and is independent of p53. Oncogene 2001;202:147-55.
5. Chang L, Karin M. Mammalian MAP kinase signalling cascades. Nature 2001;410:37-40.
6. Choi YJ, Lim SY, Woo JH, Kim YH, Kwon YK, Suh SI, et al. Sodium orthovanadate potentiates EGCG-induced apoptosis that is dependent on the ERK pathway. Biochem Biophys Res Commun 2003;305:176-85.
7. Davis RJ. Signal transduction by the JNK group of MAP kinases. Cell 2000;103:239-52.
8. Deveraux QL, Reed JC. IAP family proteins-suppressors of apoptosis. Genes Dev 1999;13:239-52.
9. Johnson GL, Lapadat R. Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 2002;298:1911-2.
10. Jones GB, Hynd G, Wright JM, Purohit A, Plourde GW 2nd, Huber RS, et al. Target-directed enediynes: designed estramycins. J Org Chem 2001;66:3688-95.
11. Jones GB, Wright JM, Hynd G, Wyatt JK, Yancisin M, Brown MA. Protein-degrading enediynes: library screening of Bergman cycloaromatization products. Org Lett 2000;2:1863-6.
12. Lee HJ, Wang CJ, Kuo HC, Chou FP, Jean LF, Tseng TH. Induction apoptosis of luteolin in human hepatoma HepG2 cells involving mitochondria translocation of Bax/Bak and activation of JNK. Toxicol Appl Pharmacol 2005;203:124-31.
13. Lin CF, Hsieh PC, Lu WD, Chiu HF, Wu MJ. A series of enediynes as novel inhibitors of topoisomerase I. Bioorg Med Chem 2001;9:1707-11.
14. Lin CF, Lu WD, Hsieh PC, Kuo YH, Chiu HF, Wang CJ, et al. Cytotoxicities and topoisomerase I inhibitory activities of 2-[2-(2-Alkynylphenyl)ethynyl] benzonitriles, 1-aryldec-3-ene-1,5-diynes, and related bis(enediynyl)arene compounds. Helv Chim Acta 2002;85:2564-75.
15. Lin CF, Lo YH, Hsieh MC, Chen YH, Wang JJ, Wu MJ. Cytotoxicities, cell cycle and caspase evaluations of 1,6-diaryl-3(Z)-hexen-1,5-diynes, 2-(6-aryl-3(Z)-hexen-1,5-diynyl)anilines and their derivatives. Bioorg Med Chem 2005;13:3565-75.
16. Lo YH, Lin CF, Hsieh MC, Wu MJ. Remarkable G2/M phase arrest and apoptotic effect performed by 2-(6-aryl-3-hexen-1,5-diynyl) benzonitrile antitumor agents. Bioorg Med Chem 2004;12:1047-53.
17. McCawley LJ, Li S, Wattenberg EV, Hudson LG. Sustained activation of the mitogen-activated protein kinase pathway. A mechanism underlying receptor tyrosine kinase specificity for matrix metalloproteinase-9 induction and cell migration. J Biol Chem 1999;274:4347-53.
18. Minden A, Karin M. Regulation and function of the JNK subgroup of MAP kinases. Biochim Biophys Acta 1997;1333:F85-104.
19. Nagata Y, Todokoro K. Requirement of activation of JNK and p38 for environmental stress-induced erythroid differentiation and apoptosis and of inhibition of ERK for apoptosis. Blood 1999;94:853-63.
20. Pace BS, Qian XH, Sangerman J, Ofori-Acquah SF, Baliga BS, Han J, et al. p38 MAP kinase activation mediatesγ-globin gene induction in erythroid progenitors. Exp Hematol 2003;31:1089-96.
21. Pastorino JG, Chen ST, Tafani M, Snyder JW, Farber JL. The overexpression of Bax produces cell death upon induction of the mitochondrial permeability transition. J Biol Chem 1998;273:7770-5.
22. Robertson JD, Orrenius S. Molecular mechanisms of apoptosis induced by cytotoxic chemicals. Crit Rev Toxicol 2000;30:609-27.
23. Roulston A, Reinhard C, Amiri P, Williams LT. Early activation of c-Jun N-terminal kinase and p38 kinase regulate cell survival in response to tumor necrosis factor alpha. J Biol Chem 1998;273:10232-9.
24. Salvesen GS, Dixit VM. Caspases: intracellular signaling by proteolysis. Cell 1997;91:443-6.
25. Takahashi R, Deveraux Q, Tamm I, Welsh K, Assa-Munt N, Salvesen GS, et al. A single BIR domain of XIAP sufficient for inhibiting caspases. J Biol Chem 1998;273:7787-90.
26. Wada T, Penninger JM. Mitogen-activated protein kinases in apoptosis regulation. Oncogene 2004;23:2838-49.
27. Wang X, Martindale JL, Holbrook NJ. Requirement for ERK activation in cisplatin-induced apoptosis. J Biol Chem 2000;275:39435-43.
28. Wu ZZ, Chien CM, Yang SH, Lin YH, Hu XW, Lu YJ, et al. Induction of G2/M phase arrest and apoptosis by a novel enediyne derivative, THDA, in chronic myeloid leukemia (K562) cells. Mol Cell Biochem 2006;292:99-105.
29. Xiao D, Singh SV. Phenethyl isothiocyanate-induced apoptosis in p53-deficient PC-3 human prostate cancer cell line is mediated by extracellular signal-regulated kinases. Cancer Res 2002;62:3615-9.